| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―07 |
Fine specificity of antibodies to SARS-CoV-2 nucleoprotein in patients with COVID-19 |
Caterina Porciani, Francesco Pisani, Maria Laura Manca, Lorenzo Pacini, Fosca Errante, Roberto Mozzo, et al. (+3) Luigi De Simone, Paola Migliorini, Federico Pratesi |
| 2 |
[GO] |
2026―Mar―14 |
Adapting covid-19 vaccination through targeted approaches: FDA-approved vaccines for the 2025-2026 season |
Rukaiah Fatma Begum, Midhun Mathew, Pratik Prashant Doshi, Swathi Suresh |
| 3 |
[GO] |
2025―Aug―27 |
A nasal vaccine candidate based on S2 and N proteins from SARS-CoV-2 generates a broad antibody response systemically and in the lower respiratory tract |
Yadira Lobaina, Rong Chen, Dania Vazquez-Blomquist, Edith Suzarte, Miaohong Zhang, Zhiqiang Zhou, et al. (+5) Yaqin Lan, Gerardo Guillen, Wen Li, Yasser Perera, Lisset Hermida |
| 4 |
[GO] |
2024―Dec―27 |
QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: a systematic review and meta-analysis |
Maria-Myrto Dourdouna, Georgia Kourlaba, Athanasios Michos |
| 5 |
[GO] |
2024―Dec―18 |
SARS-CoV-2 pathophysiology and post-vaccination severity: a systematic review |
Vanshika Rustagi, Shradheya R. R. Gupta, Chandni Talwar, Archana Singh, Zhen-Zhu Xiao, Rahul Jamwal, et al. (+4) Kiran Bala, Akash Kumar Bhaskar, Shekhar Nagar, Indrakant K. Singh |
| 6 |
[GO] |
2024―Apr―16 |
Cluster analysis of long COVID symptoms for deciphering a syndrome and its long-term consequence |
J. Niewolik, M. Mikuteit, S. Klawitter, D. Schröder, A. Stölting, K. Vahldiek, et al. (+6) S. Heinemann, F. Müller, GMN. Behrens, F. Klawonn, A. Dopfer-Jablonka, S. Steffens |
| 7 |
[GO] |
2024―Jan―26 |
Evidence of concerning decline of COVID-19 vaccination in older persons |
Camilla Mattiuzzi, Giuseppe Lippi |
| 8 |
[GO] |
2024―Jan―05 |
Response to: regarding the significance of anti-COVID-IgA antibody response in COVID-19 breakthrough infection |
Sabiha Anis, Mariam Ashfaq Khan, Areej Fatima, Fatima Kanani, Javeria Aijaz, Aneela Hussain, Samreen Sarfaraz |
| 9 |
[GO] |
2023―Dec―22 |
COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study |
Yinlan Wu, Yanhong Li, Tong Wu, Deying Huang, Jianhong Wu, Weihua Zhang, et al. (+9) Xuejun Jiang, Chaoqiong Yao, Xiuping Liang, Lu Cheng, Zehui Liao, Fang Xu, Chunyu Tan, Yi Liu, Martin Herrmann |
| 10 |
[GO] |
2023―Dec―13 |
Regarding the significance of anti-COVID-IgA antibody response in COVID-19 breakthrough infection |
Yue Chen, Jinlin Liu, Diao Yu |
| 11 |
[GO] |
2023―Oct―24 |
Association study between killer immunoglobulin-like receptor polymorphisms and susceptibility to COVID-19 disease: a systematic review and meta-analysis |
Saeed Hosseini Teshnizi, Sara Mirzazadeh, Niloofar Mashhadi, Seppo Meri, Dieter Kabelitz, Kurosh Kalantar |
| 12 |
[GO] |
2023―Sep―28 |
Elevated neutrophil-lymphocyte ratio is associated with high rates of ICU mortality, length of stay, and invasive mechanical ventilation in critically ill patients with COVID-19 |
Heitor O. Santos, Felipe M. Delpino, Octavio M. Veloso, Juliana M. R. Freire, Erlaine S. N. Gomes, Cristina G. M. Pereira |
| 13 |
[GO] |
2023―Sep―08 |
Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2 |
Atika Dhar, Sneh Lata Gupta, Pratima Saini, Kirti Sinha, Ankita Khandelwal, Rohit Tyagi, et al. (+3) Alka Singh, Priyanka Sharma, Rishi Kumar Jaiswal |
| 14 |
[GO] |
2023―Aug―29 |
How the immune response to the structural proteins of SARS-CoV-2 affects the retinal vascular endothelial cells: an immune thrombotic and/or endotheliopathy process with in silico modeling |
Işıl Kutlutürk, Ecem Önder Tokuç, Levent Karabaş, René Rückert, Mücahit Kaya, Ali Karagöz, Marion R Munk |
| 15 |
[GO] |
2023―Jul―12 |
Significance of Anti-COVID-IgA antibody response in COVID-19 breakthrough infection in vaccinated patients - a single-centered study from Pakistan |
Sabiha Anis, Mariam Ashfaq Khan, Areej Fatima, Fatima Kanani, Javeria Aijaz, Aneela Hussain, Samreen Sarfaraz |
| 16 |
[GO] |
2023―Jul―03 |
Chronic inflammatory demyelinating polyneuropathy after SARS-CoV2 vaccination: update of the literature and patient characterization |
Federica Ginanneschi, Claudia Vinciguerra, Nila Volpi, Giuseppe Piscosquito, Paolo Barone, Alessandro Rossi |
| 17 |
[GO] |
2023―Jun―14 |
COVID-19 infection: a possible induction factor for development of autoimmune diseases? |
Nikoo Saeedi, Narjes Sadat Farizani Gohari, Amir Ali Moodi Ghalibaf, Ali Dehghan, Mohammad Bagher Owlia |
| 18 |
[GO] |
2023―May―12 |
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study |
Cecilia Zivelonghi, Alessandro Dinoto, Sarosh R. Irani, Andrew McKeon, Andrea Pilotto, Alessandro Padovani, et al. (+14) Stefano Masciocchi, Eugenio Magni, Chiara R. Mancinelli, Ruggero Capra, Giorgia T. Maniscalco, Irene Volonghi, Ava Easton, Daniela Alberti, Gianluigi Zanusso, Salvatore Monaco, Gian Luca Salvagno, Giuseppe Lippi, Sergio Ferrari, Sara Mariotto |
| 19 |
[GO] |
2023―Apr―20 |
SAPHO syndrome after COVID-19 vaccination complicated with thyroid function abnormalities: a case report and literature review |
Jia-Ying Lin, Bing-Xue Bai |
| 20 |
[GO] |
2023―Apr―20 |
Update on the status of COVID-19 vaccination in Italy-April 2023 |
Camilla Mattiuzzi, Giuseppe Lippi |
| 21 |
[GO] |
2023―Apr―11 |
An assessment of the strategy and status of COVID-19 vaccination in India |
Sneh Lata Gupta, Surbhi Goswami, Ananya Anand, Namrata Naman, Priya Kumari, Priyanka Sharma, Rishi K. Jaiswal |
| 22 |
[GO] |
2023―Mar―26 |
COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report |
Vasiliki Syrmou, Christos Liaskos, Niki Ntavari, Konstantinos Mitsimponas, Theodora Simopoulou, Ioannis Alexiou, et al. (+3) Marianna Vlychou, Christina G. Katsiari, Dimitrios P. Bogdanos |
| 23 |
[GO] |
2023―Jan―06 |
COVID-19 vaccines adverse events: potential molecular mechanisms |
Malamatenia Lamprinou, Athanasios Sachinidis, Eleni Stamoula, Theofanis Vavilis, Georgios Papazisis |
| 24 |
[GO] |
2022―Oct―12 |
The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis |
Yuval Volfovitch, Avishai M. Tsur, Michael Gurevitch, Daniela Novick, Roy Rabinowitz, Mathilda Mandel, et al. (+4) Anat Achiron, Menachem Rubinstein, Yehuda Shoenfeld, Howard Amital |
| 25 |
[GO] |
2022―Sep―13 |
Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review |
Meysam Abolmaali, Fatemeh Rezania, Arman Karimi Behnagh, Negin Mahmoudi Hamidabad, Ali Gorji, Zahra Mirzaasgari |
| 26 |
[GO] |
2022―Jun―09 |
Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels |
Anthony Dobi, Arthur Dubernet, Mahary Lalarizo Rakoto, Anne-Laure Sandenon Seteyen, Damien Vagner, Grégorie Lebeau, et al. (+2) Loïc Raffray, Philippe Gasque |
| 27 |
[GO] |
2022―May―23 |
A systematic review on neutrophil extracellular traps and its prognostication role in COVID-19 patients |
Phey Liana, Iche Andriyani Liberty, Krisna Murti, Zen Hafy, Eddy Mart Salim, Mohammad Zulkarnain, Tungki Pratama Umar |
| 28 |
[GO] |
2022―May―11 |
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis |
Maurizio Benucci, Arianna Damiani, Francesca Li Gobbi, Barbara Lari, Valentina Grossi, Maria Infantino, Mariangela Manfredi |
| 29 |
[GO] |
2022―Mar―08 |
An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19 |
Pooria Fazeli, Mohammadreza Saeidnia, Mehran Erfani, Mehdi Kalani |
| 30 |
[GO] |
2022―Mar―03 |
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? |
Milena Trentinaglia, Giuseppe Lippi, Gian Luca Salvagno, Marianna G. Rispoli, Maria Vittoria De Angelis, Francesca Castellani, et al. (+14) Daniela Alberti, Giorgia T. Maniscalco, Francesca Rossi, Mara Turri, Patrizia Rossi, Elisabetta Del Zotto, Simone Fusina, Davide Cardellini, Cecilia Zivelonghi, Irene Volonghi, Salvatore Monaco, Chiara Briani, Sergio Ferrari, Sara Mariotto |
| 31 |
[GO] |
2021―Nov―16 |
Comparative structural analyses of selected spike protein-RBD mutations in SARS-CoV-2 lineages |
Urmi Roy |
| 32 |
[GO] |
2021―Nov―05 |
A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy? |
Antonio Vitiello, Francesco Ferrara |
| 33 |
[GO] |
2021―Oct―14 |
Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment-a population-based cohort study |
Khalaf Kridin, Yochai Schonmann, Arie Solomon, Erez Onn, Dana Tzur Bitan, Orly Weinstein, Arnon D. Cohen |
| 34 |
[GO] |
2021―Aug―21 |
Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease |
Giacomo Malipiero, Anna Moratto, Maria Infantino, Pierlanfranco D’Agaro, Elisa Piscianz, Mariangela Manfredi, et al. (+5) Valentina Grossi, Enrico Benvenuti, Matteo Bulgaresi, Maurizio Benucci, Danilo Villalta |
| 35 |
[GO] |
2021―Aug―19 |
COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells |
Liu Wenzhong, Li Hualan |
| 36 |
[GO] |
2021―Aug―07 |
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? |
Silvia Bozzetti, Sergio Ferrari, Serena Zanzoni, Daniela Alberti, Michele Braggio, Sara Carta, et al. (+7) Francesco Piraino, Daniele Gabbiani, Domenico Girelli, Riccardo Nocini, Salvatore Monaco, Ernesto Crisafulli, Sara Mariotto |
| 37 |
[GO] |
2021―Aug―06 |
COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators |
Mina T. Kelleni |
| 38 |
[GO] |
2021―Jul―29 |
Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab |
Maurizio Benucci, Arianna Damiani, Maria Infantino, Mariangela Manfredi, Valentina Grossi, Barbara Lari, et al. (+2) Francesca Li Gobbi, Piercarlo Sarzi-Puttini |
| 39 |
[GO] |
2021―Jun―01 |
Management of COVID-19 pneumonia in a child with NEMO deficiency |
Gulsum Alkan, Hasibe Artac, Sadiye Kubra Tuter Oz, Melike Emiroglu |
| 40 |
[GO] |
2021―Apr―29 |
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2) |
Ramin Lotfi, Rasoul Nasiri Kalmarzi, Seyed Askar Roghani |
| 41 |
[GO] |
2021―Apr―15 |
COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified |
Francesco Ferrara, Laura Pianesi, Antonio Vitiello |
| 42 |
[GO] |
2021―Apr―13 |
Correction to: Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients |
Svetlana Blitshteyn, Sera Whitelaw |
| 43 |
[GO] |
2021―Mar―30 |
Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients |
Svetlana Blitshteyn, Sera Whitelaw |
| 44 |
[GO] |
2021―Jan―25 |
A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy |
Phani Kumar Devarasetti, Liza Rajasekhar, Ritasman Baisya, K. S. Sreejitha, Yerram Keerthi Vardhan |
| 45 |
[GO] |
2020―Oct―01 |
Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development |
Daniela Calina, Chandan Sarkar, Andreea Letitia Arsene, Bahare Salehi, Anca Oana Docea, Milon Mondal, et al. (+3) Muhammad Torequl Islam, Alireza Zali, Javad Sharifi-Rad |
| 46 |
[GO] |
2020―Sep―28 |
Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2 |
Xiaolei Li, Yang Liu, Junming Li, Longhua Sun, Jibin Yang, Fei Xu, et al. (+5) Jing Zhou, Lagen Wan, Xinping Xu, Aiping Le, Wei Zhang |
| 47 |
[GO] |
2020―Sep―18 |
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine |
Darja Kanduc, Yehuda Shoenfeld |
| 48 |
[GO] |
2020―Jul―17 |
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy |
Carlo Perricone, Elena Bartoloni, Roberto Bursi, Giacomo Cafaro, Giacomo Maria Guidelli, Yehuda Shoenfeld, Roberto Gerli |